Hosts Gil Bashe and Gregg Masters welcome Shaheen E Lakhan, MD, PhD, FAAN, a brilliant physician, scientist, neurologist, and pain medicine specialist who is also the Chief Medical Officer of Click Therapeutics. They discuss the recent clinical trial results for CT-132, a prescription digital therapeutic aimed at treating episodic migraines. With nearly 1 billion people worldwide suffering from migraines, this is a huge area of unmet need. Their approach is unique in that they are not seeking to replace traditional therapeutics but rather complement them, providing patients with a more holistic treatment option. The trial demonstrated a reduction of up to three migraine days per month, which is a significant improvement in the quality of life for sufferers.

To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”.

Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen